| 臺大學術典藏 |
2022-02-09T07:10:27Z |
Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity
|
KO-JEN LI; Wu, Cheng-Han; Lu, Cheng-Hsun; Shen, Chieh-Yu; Kuo, Yu-Min; Tsai, Chang-Youh; Hsieh, Song-Chou; Yu, Chia-Li |
| 國立成功大學 |
2014-03 |
Trojan horse attack free fault-tolerant quantum key distribution protocols
|
Yang, Chun-Wei; Hwang, Tzonelih |
| 國立成功大學 |
2016-09 |
Trojan Horse Attack Free Fault-Tolerant Quantum Key Distribution Protocols Using GHZ States
|
Chang, Chih-Hung; Yang, Chun-Wei; Hwang, Tzonelih |
| 國立成功大學 |
2023 |
Trompt: Towards a Better Deep Neural Network for Tabular Data
|
Chen, K.-Y.;Chiang, P.-H.;Chou, H.-R.;Chen, T.-W.;Chang, D.T.-H. |
| 國立成功大學 |
2012-06 |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin, Jau-Chen; Wu, Yi-Ying; Wu, Jing-Yi; Lin, Tzu-Chieh; Wu, Chen-Tu; Chang, Yih-Leong; Jou, Yuh-Shan; Hong, Tse-Ming; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:21:10Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin, J.-C. and Wu, Y.-Y. and Wu, J.-Y. and Lin, T.-C. and Wu, C.-T. and Chang, Y.-L. and Jou, Y.-S. and Hong, T.-M. and Yang, P.-C.; CHEN-TU WU; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-06T05:26:21Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; Wu C.-T.; YIH-LEONG CHANG; Jou Y.-S.; Hong T.-M.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:34Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; Wu C.-T.; YIH-LEONG CHANG; Jou Y.-S.; Hong T.-M.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:00Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; Wu C.-T.; Chang Y.-L.; Jou Y.-S.; Hong T.-M.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-03-04T05:33:39Z |
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
|
Lin J.-C.; Wu Y.-Y.; Wu J.-Y.; Lin T.-C.; CHEN-TU WU; Chang Y.-L.; Jou Y.-S.; Hong T.-M.; Yang P.-C. |
